HRA presses on with trial transparency despite legal challenge
This article was originally published in Scrip
Executive Summary
Just why the London-based CRO, Richmond Pharmacology, has decided to challenge the UK Health Research Authority's clinical trial transparency policies is still not clear, but it could well be that the CRO has the HRA's new requirement on trial registration in its sights.